151 related articles for article (PubMed ID: 5896923)
1. The management of hypercalcaemia in malignant disease.
Marsden JA
Med J Aust; 1965 Sep; 2(10):411-4. PubMed ID: 5896923
[No Abstract] [Full Text] [Related]
2. [The treatment of acute hypercalcemias with furosemide].
Humbert G; Fillastre JP; Leroy J; Deshayes P
Rev Rhum Mal Osteoartic; 1973 Feb; 40(2):137-8. PubMed ID: 4740042
[No Abstract] [Full Text] [Related]
3. [Acute hypercalcemia. Treatment with Furosemide].
Humbert G; Fillastre JP; Leroy J; Robert M; Delaunay P
Nouv Presse Med; 1972 Sep; 1(31):2025-30. PubMed ID: 4678222
[No Abstract] [Full Text] [Related]
4. Intravenous etidronate in the management of malignant hypercalcemia.
Ryzen E; Martodam RR; Troxell M; Benson A; Paterson A; Shepard K; Hicks R
Arch Intern Med; 1985 Mar; 145(3):449-52. PubMed ID: 3919667
[TBL] [Abstract][Full Text] [Related]
5. Failure of corticosteroid therapy to correct the hypercalcaemia of malignant disease.
Thalassinos NC; Joplin GF
Lancet; 1970 Sep; 2(7672):537-8. PubMed ID: 4195203
[No Abstract] [Full Text] [Related]
6. Inorganic phosphate treatment of hypercalcemia of diverse etiologies.
Goldsmith RS; Ingbar SH
N Engl J Med; 1966 Jan; 274(1):1-7. PubMed ID: 5901867
[No Abstract] [Full Text] [Related]
7. [Severe hypercalcemia: response to treatment].
Pérez C; Alvarez M; Pérez I; Arriagada D
Rev Med Chil; 1988 Nov; 116(11):1124-7. PubMed ID: 3267897
[No Abstract] [Full Text] [Related]
8. [Hypercalcemia syndrome not due to primary hyperparathyroidism].
Pumarino H; Oviedo S; Michelsen H; Generini G
Rev Med Chil; 1985 Sep; 113(9):915-8. PubMed ID: 3837320
[No Abstract] [Full Text] [Related]
9. Refractory hypercalcaemia. Parathyroid adenoma or multiple myeloma?
Dalgleish AG; Gatenby PA
Med J Aust; 1984 Jan; 140(2):99-100. PubMed ID: 6694588
[TBL] [Abstract][Full Text] [Related]
10. Malignant lymphoma presenting with severe hypercalcemia.
Sirianni SR; Mora ME; Sands AM; Puckhaber D; Smith TJ
N Y State J Med; 1989 Sep; 89(9):533-5. PubMed ID: 2529457
[No Abstract] [Full Text] [Related]
11. [Somatostatin analogue treatment for malignant hypercalcemia associated with advanced breast cancer].
Shiba E; Inoue T; Akazawa K; Takai S
Gan To Kagaku Ryoho; 1996 Feb; 23(3):343-7. PubMed ID: 8712828
[TBL] [Abstract][Full Text] [Related]
12. [Hypercalcemia of tumoral origin].
Camus JP; Laveant-Hébrard C
Probl Actuels Endocrinol Nutr; 1969; 13():217-40. PubMed ID: 5404023
[No Abstract] [Full Text] [Related]
13. Clinical findings in patients with hypercalcaemia. A preliminary investigation based on biochemical screening.
Heedman PA; Stenström G
Acta Med Scand; 1973 Mar; 193(3):167-73. PubMed ID: 4693780
[No Abstract] [Full Text] [Related]
14. Hypercalcemia of malignancy.
Kessinger A; Lemon HM; Foley JF
Geriatrics; 1972 Sep; 27(9):97-106. PubMed ID: 4262293
[No Abstract] [Full Text] [Related]
15. [Hypercalcemia associated with malignant neoplastic disorders: attempt at physiopathologic interpretation. 15 cases].
Bloch-Michel H; Aristoff H; Gorins A; Dussart N
Rev Rhum Mal Osteoartic; 1969 Apr; 36(4):174-90. PubMed ID: 5402944
[No Abstract] [Full Text] [Related]
16. [Hypercalcemia in breast cancer].
Okada Y; Ogawa M; Horikoshi N; Inagaki J; Inoue K; Ikeda K; Usui N; Nakada H; Adachi K; Mukaiyama T
Gan To Kagaku Ryoho; 1984 Jul; 11(7):1468-74. PubMed ID: 6742868
[TBL] [Abstract][Full Text] [Related]
17. Letter: Mithramycin for hypercalcaemia associated with myeloma and other malignancies.
Smith IE; Powles TJ
Br Med J; 1975 Feb; 1(5952):268-9. PubMed ID: 122909
[No Abstract] [Full Text] [Related]
18. Phosphate supplementation as an adjunct in the therapy of multiple myeloma.
Goldsmith RS; Bartos H; Hulley SB; Ingbar SH; Moloney WC
Arch Intern Med; 1968 Aug; 122(2):128-33. PubMed ID: 4969948
[No Abstract] [Full Text] [Related]
19. A multicenter and open label clinical trial of zoledronic acid 4 mg in patients with hypercalcemia of malignancy.
Kawada K; Minami H; Okabe K; Watanabe T; Inoue K; Sawamura M; Yagi Y; Sasaki T; Takashima S
Jpn J Clin Oncol; 2005 Jan; 35(1):28-33. PubMed ID: 15681601
[TBL] [Abstract][Full Text] [Related]
20. Disodium pamidronate for treating severe hypercalcemia in a hemodialysis patient.
Trimarchi H; Lombi F; Forrester M; Elizondo C; Sawinski D; Pereyra H; Freixas E
Nat Clin Pract Nephrol; 2006 Aug; 2(8):459-63; quiz 464. PubMed ID: 16932480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
